DarioHealth Corp. (DRIO) Stock

About DarioHealth Corp.

DarioHealth Corp. is led by CEO Erez Raphael, employs 196 people, headquartered in US, publicly traded since 2016.

DarioHealth Corp. (DRIO) stock trades at $3.40 with a market capitalization of $33.32M. The stock is valued at a price-to-earnings (P/E) ratio of 8.41, price-to-book of 0.98, price-to-sales of 2.02. Over the past 52 weeks the stock has ranged between $3.07 and $16.55, and currently trades 79.5% below its 52-week high.

On profitability, DarioHealth Corp. generates a return on equity (ROE) of 104.15%, above the typical market range of roughly 12-15%, return on capital employed of -79.36%, an operating margin of -2.52%, a net profit margin of 322.77%.

DarioHealth Corp. by the numbers, 2016–2025

Between 2016 and 2025 DarioHealth Corp. reported revenue of $3.0M rising to $22.0M, a change of +633.3% across 10 years. Compounded, revenue has grown 22.4% a year over five years, -7.7% over three, -18.5% over the last twelve months. Net profit fell to $-42.0M.

Operating margin went from -396.0% in 2016 to -163.9% in 2025, a gain of 232.1 percentage points. The most recent net margin is 322.77%. On a trailing twelve-month basis to Jun '26, revenue is $21.0M and net profit $68.0M.

Borrowings stand at $32.0M, cash from operations was $-26.0M in the latest year, positive in 0 of the last 10.

Return on equity has averaged -78.0% over five years, and was -61.8% in the most recent year.

The share price itself has compounded at -55.8% a year over five years, -55.5% over three, -46.3% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

DarioHealth Corp. (DRIO) — frequently asked questions